Viewing Study NCT00003934

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-02-28 @ 12:21 AM
Study NCT ID: NCT00003934
Status: COMPLETED
Last Update Posted: 2013-06-05
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) View
None Adult Acute Promyelocytic Leukemia (M3) View
None Childhood Acute Promyelocytic Leukemia (M3) View
None Untreated Adult Acute Myeloid Leukemia View
None Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies View
Keywords: